Coherus BioSciences Inc (NAS:CHRS)
$ 1.69 -0.09 (-5.06%) Market Cap: 193.89 Mil Enterprise Value: 415.27 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q3 2020 Coherus BioSciences Inc Earnings Call Transcript

Nov 05, 2020 / 09:30PM GMT
Release Date Price: $18.28 (+1.27%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Coherus BioSciences 2020 Third Quarter Earnings Conference Call. My name is Ashley, and I will be your conference operator for the call today. As a reminder, this conference call is being recorded.

I would now like to turn the call over to McDavid Stilwell, Executive Vice President of Corporate Development; Investor Relations and Financial Strategy at Coherus. Please go ahead.

McDavid Stilwell
Coherus BioSciences, Inc. - EVP of Corporate Development, IR & Financial Strategy

Thank you. Good afternoon, everyone, and thank you for joining us. After close of market today, we issued a press release with our third quarter financial results. This release can be found on the Coherus BioSciences website.

This call includes forward-looking statements regarding Coherus' current expectations. These statements include, but are not limited to, statements relating to the effects of the evolving COVID-19 pandemic, our plans and expectations regarding our ongoing commercialization of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot